Support For Stewart, Feder

Please forgive my urge to share a few thoughts concerning the Stewart-Feder execution by the establishment. In my view, scientists are divided into two groups, one of which, perhaps best represented by John Edsall, practices science for its own sake and another group that is represented by those who cheer the ignominious action taken against Stewart and Feder. One group has nothing to fear from monitors of misconduct; the other group stands to lose prominence, careers, committee membership,

Written byChristian Schwabe
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

One group has nothing to fear from monitors of misconduct; the other group stands to lose prominence, careers, committee membership, "honors," and, worst of all, the incredible chunk of research money that their method allows them to extract from NIH. Scientists like Stewart and Feder are the only effective counterforce that pure science has to defend itself against overgrowth by "careerists." Federal anti-fraud agencies are mere window dressing, as Bernadine Healy has demonstrated beyond doubt.

David Baltimore's audacious comments (Franklin Hoke, page 1) make it clear that the group he de facto represents feels that its rights have been curtailed. The right to do what? What are we to tell our students? Perhaps we could explain to them, as the youth in Sparta once learned, that it is not cheating, but getting caught, that is bad. Stewart and Feder's farewell could be spiced with words from Machiavelli: "He who makes ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies